An activist-connected shareholder bought out Taisho Pharma's stake in Yomeishu Seizo, which launched an auction. KKR "won". The large activist bought more, then said they wouldn't sell but might bid.
What is covered in the Full Insight:
Introduction to Yomeishu Seizo and Recent Developments
Company Background and Core Products
Real Estate and Financial Assets Analysis
Privatization, Strategic Review, and Market Reactions